Richard F. Schlenk
ORCID: 0000-0003-2215-2059Also affiliated with Heidelberg University, University Hospital Heidelberg, National Center for Tumor Diseases, DKFZ-ZMBH Alliance, Deutsches Konsortium für Translationale Krebsforschung
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 4 papers. Top paper: “Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group”.
A Corbacioglu, V I Gaidzik, P Paschka, D Weber, M Heuser +42 more
Richard A. Larson, Dan Jones, Guido Marcucci, Thomas W. Prior, Jürgen Krauter +32 more
Albrecht Leo, Cornelia Wolf, Miriam Stenzinger, Marie Bartenschlager, Juliane Brandt +7 more
M-V. Teleanu, Irfan A. Bhatti, Susan Richter, Jens T. Siveke, Stephan N. Wagner +14 more